HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

CEP 751

inhibits TRK receptor tyrosine kinase; structure given in first source
Also Known As:
CEP-751; CEP751; KT6587
Networked: 10 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Denmeade, Samuel R: 2 articles (09/2003 - 02/2002)
2. Ratain, Mark J: 1 article (11/2004)
3. Mani, Sridhar: 1 article (11/2004)
4. Mauer, Ann M: 1 article (11/2004)
5. Vogelzang, Nicholas J: 1 article (11/2004)
6. Undevia, Samir D: 1 article (11/2004)
7. Janisch, Linda: 1 article (11/2004)
8. Rosen, Mark: 1 article (09/2003)
9. Ball, Douglas W: 1 article (09/2003)
10. Jones-Bolin, Susan: 1 article (09/2003)

Related Diseases

1. Neoplasms (Cancer)
2. Prostatic Neoplasms (Prostate Cancer)
3. Neuroblastoma
4. Thyroid Neoplasms (Thyroid Cancer)
5. Medulloblastoma

Related Drugs and Biologics

1. Phosphotransferases (Kinase)
2. tyrosine receptor (receptor, tyrosine)
3. DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)
4. Protein-Tyrosine Kinases (Tyrosine Kinase)
5. lestaurtinib
6. CEP 2563
7. CEP 751
8. Protein Kinase Inhibitors
9. Tyrosine (L-Tyrosine)
10. Hormones

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Castration